11.1 Information on toxicological effects
Acute toxicity
LD50 Oral - Rat - > 2,102 mg/kg (OECD Test Guideline 423)
LC50 Inhalation - Rat - male and female - 4 h - > 4.95 mg/l - dust/mist (OECD Test Guideline 403)
Dermal: No data available
Skin corrosion/irritation
Skin - Rabbit
Result: No skin irritation - 4 h (OECD Test Guideline 404)
Serious eye damage/eye irritation
Eyes - Rabbit
Result: No eye irritation (OECD Test Guideline 405)
Respiratory or skin sensitization
May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Germ cell mutagenicity
Test Type: Ames test
Test system: S. typhimurium
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 471
Result: negative
Test Type: Chromosome aberration test in vitro
Test system: Chinese hamster lung cells
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 473
Result: negative
Test Type: in vitro assay
Test system: Human lymphocytes
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 487
Result: negative
Carcinogenicity
Classified based on available data. For more details, see section 2
Reproductive toxicity
Classified based on available data. For more details, see section 2
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
Repeated dose toxicity - Rat - male and female - Gavage - 13 Weeks - No observed adverse effect level - >= 1,051 mg/kg
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.